6.
Younossi ZM, Paik JM, Lazarus JV, et al. Projected global clinical, humanistic, and economic impact of metabolic dysfunction-associated steatohepatitis (MASH): the cost of inaction based on data from nine countries. Clin Gastroenterol Hepatol 2026; 24: 1016-34.